Listed Companies
Search for Company
Latest Results
Financial Reports
ESG Reports
Announcements / Notices
Returns on Share Capital
Circulars
Prospectuses
Press Releases
Presentations / Webcasts
Stock Quotes
Corporate Governance
Upcoming Events
Sign Up
Seminars / Conferences
IR Services Directory
Investment Community
Resource Center
HK Statutory Notices
Pharmaxis Ltd
Press Releases
Please download the latest "
Acrobat Reader
" to view the PDF.
2010-December-20
Bronchitol EU Marketing Authorisation Update (in PDF)
2010-December-16
Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial (in PDF)
2010-December-15
Pharmaxis Holds Pre-NDA Meeting with FDA for Bronchitol (in PDF)
2010-December-13
Bronchitol Recommended for Approval by Australian Advisory Committee (in PDF)
2010-December-7
Phase II Trial of ASM8 in Asthma Commences (in PDF)
2010-October-22
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results (in PDF)
2010-October-20
2010 Annual General Meeting Chairman's Address (in PDF)
2010-October-20
Pharmaxis Chief Executive Officer Resumes Office (in PDF)
2010-October-12
Pharmaxis Quarterly Investor Conference Call (in PDF)
2010-October-6
US Food and Drug Administration Approves Aridol (in PDF)
2010-August-31
Pharmaxis Announces Agreement for European Marketing of Bronchitol (in PDF)
2010-July-20
Quarterly Report to Shareholders and Investor Conference Call (in PDF)
2010-July-8
Update on Pharmaxis Chief Executive Officer (in PDF)
2010-June-22
Pharmaxis Investor Conference Call (in PDF)
2010-June-22
Pharmaxis Announces Results for Second Phase III Trial of Bronchitol in Cystic Fibrosis (in PDF)
2010-May-17
Pharmaxis Announces Sustained Benefit in Cystic Fibrosis Following Long Term Bronchitol Treatment (in PDF)
2010-April-27
Pharmaxis Provides FDA Resubmission for Aridol U.S. Marketing Application (in PDF)
2010-April-14
Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis (in PDF)
2010-April-12
Pharmaxis Investor Conference Call (in PDF)
2010-March-11
Pharmaxis Completes Phase II Clinical Study with ASM8 in Asthma Patients (in PDF)
2010-February-9
Pharmaxis Completes Acquisition of Canadian Company TOPIGEN Pharmaceuticals Inc. (in PDF)
2010-February-9
Pharmaxis Completes Clinical Trial with the Antifibrotic Agent, PXS25 (in PDF)
2010-January-22
Pharmaxis Investor Conference Call (in PDF)
2010-January-12
Pharmaxis to Acquire Canadian Company TOPIGEN Pharmaceuticals Inc. (in PDF)
2017
2017 Press Releases
2016
2016 Press Releases
2015
2015 Press Releases
2014
2014 Press Releases
2013
2013 Press Releases
2012
2012 Press Releases
2011
2011 Press Releases
2009
2009 Press Releases
2008
2008 Press Releases
2007
2007 Press Releases
2006
2006 Press Releases
2005
2005 Press Releases
2004
2004 Press Releases
Company's Index
irasia.com